News
Proposed cuts threaten health insurance for tens of millions, tariffs will drive up drug prices, and key programs are being ...
Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S. regulators saying that it sees a pathway to resolving issues with the FDA, sending ...
The U.S. Food and Drug Administration said on Thursday all its centers will have to be deploy artificial intelligence internally immediately, with full integration on June 30.
According to WHO, India accounted for the highest share of global tuberculosis cases in 2023—26%. However, the country has a ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
Columbia University and NewYork-Presbyterian Hospital agreed to pay $750 million to settle hundreds of sexual abuse claims ...
The NIH plans to develop whole-virus vaccines that would provide universal immunity against all strains of influenza and COVID-19.
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
With a demand that vaccine boosters be tested against placebos, RFK Jr. puts an old antivaccine claim at the forefront of government health policy.
Stat: Vinay Prasad's FDA Speech: Praises Staff, Embraces Evidence In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his admiration for agency ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results